MENU
RLYB
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Rallybio (RLYB) Ownership - Who owns Rallybio?

Rallybio Corp is a clinical-stage biotechnology company comprised of experienced biopharma industry leaders with extensive research, development, and rare disease expertise with a mission to develop and commercialize life-transforming therapies for patients with severe and rare diseases... Show more

Profile

Industry
N/A
Address
234 Church Street
Phone
+1 203 859-3820
Employees
25
Web
https://www.rallybio.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
91.99M
P/E Ratio
N/A
Total Cash
46.8M
Projected Growth
N/A
Total Debt
154K
Revenue
858K
Risk (Beta)
0.56
Dividend Yield
N/A
Total Cash/Share
8.07
Total Debt/Equity
N/A
Revenue/Share
0.15 USD as % of share price
View a ticker or compare two or three
RLYB
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Details
Industry
N/A
Address
234 Church Street
Phone
+1 203 859-3820
Employees
25
Web
https://www.rallybio.com